A phase II trial to assess the activity of gemcitabine and docetaxel as first line chemotherapy treatment in patients with unresectable leiomyosarcoma von Seddon, Beatrice, Scurr, Michelle, Jones, Robin L, Wood, Zoe, Propert-Lewis, Cerys, Fisher, Cyril, Flanagan, Adrienne, Sunkersing, Jonanthan, A'Hern, Roger, Whelan, Jeremy, Judson, Ian

Volltext